MedPath

Effect of Sublingual Atropine on Sialorrhea Induced by Clozapine

Phase 3
Conditions
Clozapin induced sialorrhea.
Registration Number
IRCT20221101056373N1
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
62
Inclusion Criteria

Age 18 to 60 years
Diagnosed schizophrenia
Current use of Clozapine for treatment
Presence of drooling

Exclusion Criteria

Pregnancy and breastfeeding
Cardiovascular problems (arrhythmia, blood pressure, etc.)
History of taking other anticholinergics

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sialorrhea. Timepoint: For 4 weeks and every night 1 hour before sleep. Method of measurement: Visual analogue scale and Drooling Rating Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath